Glucotrack Amends PIPE Warrants to Require Shareholder Approval Under Nasdaq Rule 5635(d)
Glucotrack entered into an amendment to its Common Warrants issued in the August 4, 2026 private placement. The change prevents any warrant exercises or related share issuances until stockholders approve the full issuance under Nasdaq Listing Rule 5635(d) and other applicable Nasdaq rules. The amen…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.